Author: Andy Gordon

I made my chops as an entrepreneur and investor with over 30 years of experience at building wealth for myself and others. I graduated from the London School of Economics a year after the bicentennial. By the way, this is the same school that produced 34 heads of state including John F. Kennedy… and another 18 Nobel Laureates…

Subscribe to ANDREW's feed.

Leveraged buyout king KKR is now looking into pre-IPO startup investing. It’s a smart move.
Premium
A look at the venture capital funnel shows how retail investors can profit where VCs can’t.

Facebook’s Coin Will Repackage the Status Quo

By Andy Gordon on May 8, 2019

Facebook is already being hailed as revolutionary for looking to create its own digital coin. But it hardly fits that description.
Premium

Everytable Expands Beyond the Kitchen

By Andy Gordon on May 6, 2019

Everytable is expanding its vision... and it’s looking to replace a workplace staple.
Premium

Earn Basic Attention Tokens for Using Brave

By Andy Gordon on April 30, 2019

Airdrops are a great way to earn free crypto. But even better than a temporary airdrop is a crypto giveaway without a deadline. That’s what Brave offers. Brave, headed by co-founder and CEO Brendan Eich (creator of the JavaScript programming language and former Mozilla CEO), is a privacy-focused browser…

The Smart Money Strategy for Surviving Crypto Winter

By Andy Gordon on April 24, 2019

Crypto prices are not a reflection of crypto progress. And the smart money knows it.
Premium

Bakkt Heads to New York to Appease the CFTC

By Andy Gordon on April 19, 2019

Editor’s Note: Adam Sharp is away on vacation this week (though he’ll undoubtedly still check CoinMarketCap every day). So Andy Gordon is filling in. Dear Member, When Bakkt gets its government approval, it will mark a turning point for the crypto community. And, yes – I said when, not if.
U.S. tax guidance on crypto is absurdly lacking. And rather than clarify its rules, the IRS is cracking down on confused investors.
Premium
About a third of epilepsy patients don’t respond to conventional medication. But a growing body of medical research is giving them hope.

Startups Ready to Disrupt Enterprise Markets

By Andy Gordon on April 10, 2019

We’ve seen startups tackling all parts of the consumer markets. But what about the enterprise markets?
Premium
Andy Gordon catches up with VirZOOM to learn about its progress in partnerships and pricing.

Bitcoin Spikes While Crypto Makes Steady Progress

By Andy Gordon on April 3, 2019

Nobody can say for sure why bitcoin’s price spiked this week. But while price movements are grabbing headlines, quiet progress is being made behind the scenes.
Premium
The company we’re recommending is working to reverse climate change - and its interests are perfectly aligned with its investors.

Getting in Before the IPO Party Starts

By Andy Gordon on March 27, 2019

CNBC can’t decide whether IPOs are good or bad for investors. It ought to subscribe to Early Investing...

Seven Reasons Why Startups Fail

By Andy Gordon on March 20, 2019

Startups can fail for a number of reasons. And for founders, clarity often comes late.